INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

CUECue Biopharma, Inc.

CIK 0001645460

EDGAR filingsOpen in network
Disclosed transactions17
Buys / sells0 / 12
Max Insider Score34
Connections5with evidence

CUE · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$30K
1,087 sh
Oct 12, 2026Oct 14, 2026
traded Oct 12, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Ray SumitaChief Legal Compliance Officer, Corporate Secretary · Oct 14, 2026
  • ← Insider ofevidence
    Meluzio Michael VincentVP, Prin. Accounting Officer · Aug 17, 2026
  • ← Insider ofevidence
    Lin Shao-LeeDirector, Chief Executive Officer · Aug 14, 2026
27
MV
Meluzio Michael VincentVP, Prin. Accounting Officer
CUECue Biopharma, Inc.
Open-market sale
SELL
$32K
1,144 sh
Oct 12, 2026
Oct 14, 2026
traded Oct 12, 2026
+2d
SEC FORM 4

Evidence

34
RS
Ray SumitaChief Legal Compliance Officer, Corporate Secretary
CUECue Biopharma, Inc.
Open-market sale
SELL$52K
1,844 sh
Oct 12, 2026Oct 14, 2026
traded Oct 12, 2026
+2dSEC FORM 4

Evidence

33
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$275K
10.0K sh
Oct 12, 2026Oct 14, 2026
traded Oct 12, 2026
+2dSEC FORM 4

Evidence

21
MV
Meluzio Michael VincentVP, Prin. Accounting Officer
CUECue Biopharma, Inc.
Option exercise
M—
13.6K sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC FORM 4

Evidence

17
MV
Meluzio Michael VincentVP, Prin. Accounting Officer
CUECue Biopharma, Inc.
Option exercise
M—
13.6K sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC FORM 4

Evidence

33
MV
Meluzio Michael VincentVP, Prin. Accounting Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$125K
4,106 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC FORM 4

Evidence

26
MV
Meluzio Michael VincentVP, Prin. Accounting Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$93.39
3 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC FORM 4

Evidence

26
MV
Meluzio Michael VincentVP, Prin. Accounting Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$45K
1,519 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC FORM 4

Evidence

13
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Option exercise
M—
109.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

29
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$160K
5,775 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

25
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$147K
5,423 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC FORM 4

Evidence

25
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$67K
2,375 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC FORM 4

Evidence

28
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$308K
10.5K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC FORM 4

Evidence

21
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Option exercise
M—
109.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

32
LL
Lin Shao-LeeDirector, Chief Executive Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$924K
34.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

9
MM
Meehan Viola MongDirector
CUECue Biopharma, Inc.
Grant or award
A—
1,626 sh
May 30, 2026Jun 2, 2026
traded May 30, 2026
+3dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Meehan Viola MongDirector · Jun 2, 2026